'김갑성' 기자의 전체기사
-
SanegeneBio Announces RNAi Licensing and Research C…
[ 메디채널 김갑성 기자 ] -Companies will collaborate on RNAi research for metabolic disease targets BOSTON, Nov. 8, 2025 -- SanegeneBio, a clinical-stage biotechnology company developing innovative RNAi therapeutics, today announced a global research and licensing collaboration with Eli Lilly and Company ("Lilly"). The companies will collaborate to advance RNAi candidates for metabolic diseases, based on SanegeneBio's proprietary tissue selective delivery technology, LEAD™ (Ligand and Enhancer Assisted Delivery). SanegeneBio will be responsible for discovery and identificatio
- 김갑성 기자
- 2025-11-08 18:00
-
inne Debuts at CIIE with Global Launch of Two New Products
SHANGHAI, Nov. 8, 2025 -- The 8th China International Import Expo (CIIE) commenced on Nov. 5 in Shanghai, China. The world's leading children's nutrition brand inne® was invited to participate, showcasing a range of its innovative achievements on this international stage and seizing the opportunity to share in China's development alongside global enterprises. Under the exhibition theme "Scientific Nutrition for a Shared Healthy Future," inne® unveiled the "Children's Calcium Quality Standard" on-site and globally launched two new products: inne® Women's
- 김갑성 기자
- 2025-11-08 11:23
-
Get Ready for the Holidays as VARON Launches Black Friday E…
NEW YORK, Nov. 7, 2025 -- As the holiday season approaches, one essential product that continues to improve lives is the oxygen concentrator. For individuals living with chronic respiratory conditions, having reliable access to supplemental oxygen can make a world of difference—enhancing comfort, mobility, and confidence in daily life. Just ahead of Black Friday, VARON, a trusted provider of portable oxygen concentrators and home oxygen concentrator machines, has launched its Black Friday Early Access Sale—offering a 20% sitewide discount and up to 40% off featur
- 김갑성 기자
- 2025-11-07 23:31
-
Lunit AI Maps the Tumor-Immune Landscape to Predict Immu…
Studies reveal how the Lunit SCOPE® suite identifies immunotherapy-responsive subtypes, standardizes immune phenotyping, and accelerates antibody-based target discovery SEOUL, South Korea, Nov. 7, 2025 -- Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced the presentation of three studies at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting, taking place November 5-9 in Maryland, U.S. The findings highlight how Lunit's AI-powered digital pathology technologies—Lunit SCOPE IO® and Lunit SCOPE®
- 김갑성 기자
- 2025-11-07 22:05
-
HanchorBio Presents Two Late-Breaking Abstracts at the So…
[ 메디채널 김갑성 기자 ] Late-breaking poster presentations show HCB101's favorable safety, strong receptor occupancy, and promising monotherapy and combination activity in tumors historically unresponsive to immunotherapy TAIPEI, SHANGHAI, and SAN FRANCISCO, Nov. 7, 2025 -- HanchorBio Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, today announced the presentation of two late-breaking abstracts on its lead asset, HCB101, at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
- 김갑성 기자
- 2025-11-07 22:00
-
2025 Aurora Prize for Awakening Humanity Awarded to Dr. Jamal E…
Head of Al Nao Hospital in Sudan recognized for sustaining critical medical care amid civil warand saving hundreds of lives NEW YORK, Nov. 7, 2025 -- The Aurora Humanitarian Initiative announced Thursday evening that Dr. Jamal Eltaeb has been named the 2025 Aurora Prize Laureate. The $1 million Aurora Prize for Awakening Humanity honors individuals who risk their lives to save others. This year, Aurora recognizes Dr. Eltaeb's extraordinary courage and steadfast dedication to providing care for those trapped in conflict. Amid Sudan's devastating civil war and the
- 김갑성 기자
- 2025-11-07 21:59
-
Brii Biosciences Announces Publication of Phase 2 ENSURE S…
Findings provide scientific insights into the contribution of small interfering RNA (siRNA) and therapeutic vaccination towards the HBV functional cure strategy DURHAM, N.C. and BEIJING, Nov. 7, 2025 -- Brii Biosciences Limited ("Brii Bio," or the "Company," stock code: 2137.HK), a biotechnology company developing therapies to improve patient health across diseases with high unmet medical need, today announced the publication of results from its Phase 2 ENSURE study in the peer-reviewed journal Nature Medicine. The study evaluates the efficacy and safet
- 김갑성 기자
- 2025-11-07 21:30
-
EBR Systems Achieves First Enrollments in the WiSE-UP Study for H…
The WiSE-UP post-approval study is gathering real-world evidence from commercially treated patients using the WiSE® left ventricular endocardial pacing (LVEP) system. Key Highlights: The first two patients have now been enrolled in the WiSE-UP post-approval study by Dr Devi Nair from St Bernards Heart & Vascular Center, Arkansas The EBR-sponsored study will evaluate real-world outcomes for heart failure patients receiving the FDA-approved WiSE® System for delivering LVEP in patients unable to receive traditional cardiac resynchronization therapy (CRT) T
- 김갑성 기자
- 2025-11-07 21:00
-
Coreline Soft Unveils AVIEW 2.0 at RSNA 2025: Next-Generation AI Pla…
CHICAGO and SEOUL, South Korea, Nov. 7, 2025 -- Coreline Soft will introduce its groundbreaking chest AI platform AVIEW 2.0 at RSNA 2025 (November 30–December 4, Chicago), demonstrating how unified AI automation is fundamentally transforming radiology workflows and elevating diagnostic precision across pulmonary, cardiac, and airway pathologies. AVIEW 2.0 represents a paradigm shift from task-specific tools to an integrated diagnostic ecosystem. The platform seamlessly combines lung-cancer screening (LCS), coronary-artery calcium scoring (CAC), and COPD quantifica
- 김갑성 기자
- 2025-11-07 21:00
-
'Coffee Diplomacy' at APEC: Korea-U.S. Startup Imunika Goes Vir…
Japan's newly appointed Foreign Minister Toshimitsu Motegi sparked an unexpected viral moment at APEC 2025 after stopping by Imunika — the official coffee sponsor of APEC 2025 Korea, a Korea–U.S. startup redefining "Wellness Specialty Coffee." SEOUL, South Korea and WASHINGTON, Nov. 7, 2025 -- A quiet exchange at the APEC 2025 Korea Summit became one of the event's most unexpected stories. Toshimitsu Motegi, Japan's newly appointed Foreign Minister — soon to help steer Japan–U.S. tariff negotiations — was filmed sampling Imunika, a small bio-fermented coffee startup that unex
- 김갑성 기자
- 2025-11-07 21:00
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 5하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 6대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 7만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2026-01-31_SAT
- 도코모, 아두나와 글로벌 네트워크 API 확장을 위한 파트너십 계약 체결 23:19
- JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL 20:58
- Sanyou Bio's Decade: From an Intelligent Super-Trillion Antibody Library to the "Innovation Hub for Original Drug Discovery" 16:15
- CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK 12:05
- Origin Agritech Announces Fiscal Year 2025 Results 06:00
- White Pearl Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering 05:47
- Planet Green Holdings Corp. Provides Response to Unusual Market Action 05:05
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2026년 02월 01일 00시 50분